Evidence map›Paper›PMID 25733474›Full record

ArticleThe Journal of nutrition2015

Multivitamin-mineral use is associated with reduced risk of cardiovascular disease mortality among women in the United States.

Regan L Bailey, Tala H Fakhouri, Yikyung Park, Johanna T Dwyer, Paul R Thomas, Jaime J Gahche, Paige E Miller, Kevin W Dodd, Christopher T Sempos, David M Murray

Abstract read
In one paragraph

Article in The Journal of nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Homocysteine-lowering interventions for preventing cardiovascular events.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Predictors of toxic metal exposures among US women of reproductive age.Journal of exposure science & environmental epidemiology · 2019
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Regan L BaileyOffices of Dietary Supplements and baileyr@mail.nih.gov.
Tala H FakhouriNational Center for Health Statistics, CDC, Hyattsville, MD.
Yikyung ParkNational Cancer Institute, NIH, Bethesda, MD; and.
Johanna T DwyerOffices of Dietary Supplements and.
Paul R ThomasOffices of Dietary Supplements and.
Jaime J GahcheNational Center for Health Statistics, CDC, Hyattsville, MD.
Paige E MillerNational Cancer Institute, NIH, Bethesda, MD; and.
Kevin W DoddNational Cancer Institute, NIH, Bethesda, MD; and.
Christopher T SemposOffices of Dietary Supplements and.
David M MurrayDisease Prevention.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultivitamin-mineral (MVM) products are the most commonly used supplements in the United States, followed by multivitamin (MV) products. Two randomized clinical trials (RCTs) did not show an effect of MVMs or MVs on cardiovascular disease (CVD) mortality; however, no clinical trial data are available for women with MVM supplement use and CVD mortality.

objectiveThe objective of this research was to examine the association between MVM and MV use and CVD-specific mortality among US adults without CVD.

methodsA nationally representative sample of adults from the restricted data NHANES III (1988-1994; n = 8678; age ≥40 y) were matched with mortality data reported by the National Death Index through 2011 to examine associations between MVM and MV use and CVD mortality by using Cox proportional hazards models, adjusting for multiple potential confounders.

resultsWe observed no significant association between CVD mortality and users of MVMs or MVs compared with nonusers; however, when users were classified by the reported length of time products were used, a significant association was found with MVM use of >3 y compared with nonusers (HR: 0.65; 95% CI: 0.49, 0.85). This finding was largely driven by the significant association among women (HR: 0.56; 95% CI: 0.37, 0.85) but not men (HR: 0.79; 95% CI: 0.44, 1.42). No significant association was observed for MV products and CVD mortality in fully adjusted models.

conclusionsIn this nationally representative data set with detailed information on supplement use and CVD mortality data ∼20 y later, we found an association between MVM use of >3 y and reduced CVD mortality risk for women when models controlled for age, race, education, body mass index, alcohol, aspirin use, serum lipids, blood pressure, and blood glucose/glycated hemoglobin. Our results are consistent with the 1 available RCT in men, indicating no relation with MVM use and CVD mortality.

Indexed as

Dietary SupplementsRisk Reduction BehaviorBlood GlucoseBlood PressureBody Mass IndexCardiovascular DiseasesCross-Sectional StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedNutrition SurveysProportional Hazards ModelsRisk FactorsTrace ElementsBlood GlucoseTrace ElementsVitaminscardiovascular diseasedietary supplementmortalitymultivitamin-mineralNHANES

Identifiers

PMID25733474
PMCPMC4336535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.